{"entity":{"type":"insider","cik":"0001427569","url":"/insider/0001427569","json_url":"/insider/0001427569.json","name":"Viret Jean-Frederic","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":29,"n_filings":23,"first":"2016-09-28","last":"2021-02-03","span_basis":"filed_date"},"name_variants":[{"name":"Viret Jean-Frederic","source":"filing","n_filings":23,"first_seen":"2016-09-28","last_seen":"2021-02-03"}],"transactions":[{"id":4146705,"accession":"0001567619-21-002141","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001567619-21-002141","line_url":"/filing/0001567619-21-002141#line-2","is_derivative":false,"issuer_cik":"0001427569","issuer_name":"Coherus BioSciences, Inc.","issuer_ticker":"CHRS","issuer_name_source":null,"issuer_url":"/issuer/0001427569","owner_cik":"0001427569","owner_name":"Viret Jean-Frederic","owner_display_name":"Viret Jean-Frederic","owner_url":"/insider/0001427569","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7402.0,"shares_display":"7,402","price_per_share":21.55,"price_display":"21.55","price_state":"stated","total_value":159513.1,"total_display":"159,513.10","total_whole":"159,513","shares_owned_after":61295.0,"shares_owned_after_display":"61,295","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-02-01","filed_date":"2021-02-03","scope":"insider"},{"id":4698775,"accession":"0001567619-21-001600","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001567619-21-001600","line_url":"/filing/0001567619-21-001600","is_derivative":false,"issuer_cik":"0001427569","issuer_name":"Coherus BioSciences, Inc.","issuer_ticker":"CHRS","issuer_name_source":null,"issuer_url":"/issuer/0001427569","owner_cik":"0001427569","owner_name":"Viret Jean-Frederic","owner_display_name":"Viret Jean-Frederic","owner_url":"/insider/0001427569","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":46144.0,"shares_display":"46,144","price_per_share":19.953536754507628,"price_display":"19.95","price_state":"stated","total_value":920736.0,"total_display":"920,736.00","total_whole":"920,736","shares_owned_after":67439.0,"shares_owned_after_display":"67,439","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-01-25","filed_date":"2021-01-27","scope":"insider","n_lines":2},{"id":3107037,"accession":"0001567619-20-020095","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001567619-20-020095","line_url":"/filing/0001567619-20-020095#line-2","is_derivative":false,"issuer_cik":"0001427569","issuer_name":"Coherus BioSciences, Inc.","issuer_ticker":"CHRS","issuer_name_source":null,"issuer_url":"/issuer/0001427569","owner_cik":"0001427569","owner_name":"Viret Jean-Frederic","owner_display_name":"Viret Jean-Frederic","owner_url":"/insider/0001427569","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock, $0.0001 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1995.0,"shares_display":"1,995","price_per_share":17.4919,"price_display":"17.49","price_state":"stated","total_value":34896.3405,"total_display":"34,896.34","total_whole":"34,896","shares_owned_after":38769.0,"shares_owned_after_display":"38,769","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-11-17","filed_date":"2020-11-19","scope":"insider"},{"id":3227883,"accession":"0001567619-20-017922","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001567619-20-017922","line_url":"/filing/0001567619-20-017922#line-1","is_derivative":false,"issuer_cik":"0001427569","issuer_name":"Coherus BioSciences, Inc.","issuer_ticker":"CHRS","issuer_name_source":null,"issuer_url":"/issuer/0001427569","owner_cik":"0001427569","owner_name":"Viret Jean-Frederic","owner_display_name":"Viret Jean-Frederic","owner_url":"/insider/0001427569","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock, $0.0001 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6144.0,"shares_display":"6,144","price_per_share":19.0,"price_display":"19.00","price_state":"stated","total_value":116736.0,"total_display":"116,736.00","total_whole":"116,736","shares_owned_after":40423.0,"shares_owned_after_display":"40,423","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-10-14","filed_date":"2020-10-16","scope":"insider"},{"id":2501219,"accession":"0001567619-20-011016","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001567619-20-011016","line_url":"/filing/0001567619-20-011016#line-1","is_derivative":false,"issuer_cik":"0001427569","issuer_name":"Coherus BioSciences, Inc.","issuer_ticker":"CHRS","issuer_name_source":null,"issuer_url":"/issuer/0001427569","owner_cik":"0001427569","owner_name":"Viret Jean-Frederic","owner_display_name":"Viret Jean-Frederic","owner_url":"/insider/0001427569","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock, $0.0001 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1278.0,"shares_display":"1,278","price_per_share":17.66,"price_display":"17.66","price_state":"stated","total_value":22569.48,"total_display":"22,569.48","total_whole":"22,569","shares_owned_after":46567.0,"shares_owned_after_display":"46,567","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-05-20","filed_date":"2020-05-22","scope":"insider"},{"id":2163913,"accession":"0001567619-20-004636","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001567619-20-004636","line_url":"/filing/0001567619-20-004636#line-2","is_derivative":false,"issuer_cik":"0001427569","issuer_name":"Coherus BioSciences, Inc.","issuer_ticker":"CHRS","issuer_name_source":null,"issuer_url":"/issuer/0001427569","owner_cik":"0001427569","owner_name":"Viret Jean-Frederic","owner_display_name":"Viret Jean-Frederic","owner_url":"/insider/0001427569","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock, $0.0001 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3159.0,"shares_display":"3,159","price_per_share":22.3336,"price_display":"22.33","price_state":"stated","total_value":70551.8424,"total_display":"70,551.84","total_whole":"70,552","shares_owned_after":46841.0,"shares_owned_after_display":"46,841","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-02-19","filed_date":"2020-02-21","scope":"insider"},{"id":3305496,"accession":"0001567619-20-001235","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001567619-20-001235","line_url":"/filing/0001567619-20-001235","is_derivative":false,"issuer_cik":"0001427569","issuer_name":"Coherus BioSciences, Inc.","issuer_ticker":"CHRS","issuer_name_source":null,"issuer_url":"/issuer/0001427569","owner_cik":"0001427569","owner_name":"Viret Jean-Frederic","owner_display_name":"Viret Jean-Frederic","owner_url":"/insider/0001427569","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock, $0.0001 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6318.0,"shares_display":"6,318","price_per_share":19.85182757201646,"price_display":"19.85","price_state":"stated","total_value":125423.8466,"total_display":"125,423.85","total_whole":"125,424","shares_owned_after":49639.0,"shares_owned_after_display":"49,639","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-01-15","filed_date":"2020-01-17","scope":"insider","n_lines":2},{"id":7868973,"accession":"0001567619-19-022077","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001567619-19-022077","line_url":"/filing/0001567619-19-022077#line-2","is_derivative":false,"issuer_cik":"0001427569","issuer_name":"Coherus BioSciences, Inc.","issuer_ticker":"CHRS","issuer_name_source":null,"issuer_url":"/issuer/0001427569","owner_cik":"0001427569","owner_name":"Viret Jean-Frederic","owner_display_name":"Viret Jean-Frederic","owner_url":"/insider/0001427569","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock, $0.0001 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3159.0,"shares_display":"3,159","price_per_share":19.5859,"price_display":"19.59","price_state":"stated","total_value":61871.8581,"total_display":"61,871.86","total_whole":"61,872","shares_owned_after":3303.0,"shares_owned_after_display":"3,303","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-11-20","filed_date":"2019-11-22","scope":"insider"},{"id":8406418,"accession":"0001567619-19-021956","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001567619-19-021956","line_url":"/filing/0001567619-19-021956#line-1","is_derivative":false,"issuer_cik":"0001427569","issuer_name":"Coherus BioSciences, Inc.","issuer_ticker":"CHRS","issuer_name_source":null,"issuer_url":"/issuer/0001427569","owner_cik":"0001427569","owner_name":"Viret Jean-Frederic","owner_display_name":"Viret Jean-Frederic","owner_url":"/insider/0001427569","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock, $0.0001 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3112.0,"shares_display":"3,112","price_per_share":18.8809,"price_display":"18.88","price_state":"stated","total_value":58757.3608,"total_display":"58,757.36","total_whole":"58,757","shares_owned_after":3303.0,"shares_owned_after_display":"3,303","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-11-18","filed_date":"2019-11-20","scope":"insider"},{"id":7938975,"accession":"0000899243-19-025822","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-19-025822","line_url":"/filing/0000899243-19-025822#line-1","is_derivative":false,"issuer_cik":"0001427569","issuer_name":"Coherus BioSciences, Inc.","issuer_ticker":"CHRS","issuer_name_source":null,"issuer_url":"/issuer/0001427569","owner_cik":"0001427569","owner_name":"Viret Jean-Frederic","owner_display_name":"Viret Jean-Frederic","owner_url":"/insider/0001427569","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock, $0.0001 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1388.0,"shares_display":"1,388","price_per_share":19.02,"price_display":"19.02","price_state":"stated","total_value":26399.76,"total_display":"26,399.76","total_whole":"26,400","shares_owned_after":6385.0,"shares_owned_after_display":"6,385","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-10-18","filed_date":"2019-10-22","scope":"insider"},{"id":8308639,"accession":"0000899243-19-025758","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-19-025758","line_url":"/filing/0000899243-19-025758#line-2","is_derivative":false,"issuer_cik":"0001427569","issuer_name":"Coherus BioSciences, Inc.","issuer_ticker":"CHRS","issuer_name_source":null,"issuer_url":"/issuer/0001427569","owner_cik":"0001427569","owner_name":"Viret Jean-Frederic","owner_display_name":"Viret Jean-Frederic","owner_url":"/insider/0001427569","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock, $0.0001 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3159.0,"shares_display":"3,159","price_per_share":19.0,"price_display":"19.00","price_state":"stated","total_value":60021.0,"total_display":"60,021.00","total_whole":"60,021","shares_owned_after":7773.0,"shares_owned_after_display":"7,773","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-10-16","filed_date":"2019-10-18","scope":"insider"},{"id":8437982,"accession":"0000899243-19-024242","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-19-024242","line_url":"/filing/0000899243-19-024242#line-1","is_derivative":false,"issuer_cik":"0001427569","issuer_name":"Coherus BioSciences, Inc.","issuer_ticker":"CHRS","issuer_name_source":null,"issuer_url":"/issuer/0001427569","owner_cik":"0001427569","owner_name":"Viret Jean-Frederic","owner_display_name":"Viret Jean-Frederic","owner_url":"/insider/0001427569","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock, $0.0001 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":740.0,"shares_display":"740","price_per_share":21.78,"price_display":"21.78","price_state":"stated","total_value":16117.2,"total_display":"16,117.20","total_whole":"16,117","shares_owned_after":7773.0,"shares_owned_after_display":"7,773","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-09-23","filed_date":"2019-09-25","scope":"insider"},{"id":8091686,"accession":"0000899243-19-023989","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-19-023989","line_url":"/filing/0000899243-19-023989#line-2","is_derivative":false,"issuer_cik":"0001427569","issuer_name":"Coherus BioSciences, Inc.","issuer_ticker":"CHRS","issuer_name_source":null,"issuer_url":"/issuer/0001427569","owner_cik":"0001427569","owner_name":"Viret Jean-Frederic","owner_display_name":"Viret Jean-Frederic","owner_url":"/insider/0001427569","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock, $0.0001 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3159.0,"shares_display":"3,159","price_per_share":20.4368,"price_display":"20.44","price_state":"stated","total_value":64559.8512,"total_display":"64,559.85","total_whole":"64,560","shares_owned_after":8513.0,"shares_owned_after_display":"8,513","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-09-18","filed_date":"2019-09-20","scope":"insider"},{"id":8308547,"accession":"0000899243-19-022360","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000899243-19-022360","line_url":"/filing/0000899243-19-022360","is_derivative":false,"issuer_cik":"0001427569","issuer_name":"Coherus BioSciences, Inc.","issuer_ticker":"CHRS","issuer_name_source":null,"issuer_url":"/issuer/0001427569","owner_cik":"0001427569","owner_name":"Viret Jean-Frederic","owner_display_name":"Viret Jean-Frederic","owner_url":"/insider/0001427569","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock, $0.0001 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6318.0,"shares_display":"6,318","price_per_share":21.70851893004115,"price_display":"21.71","price_state":"stated","total_value":137154.4226,"total_display":"137,154.42","total_whole":"137,154","shares_owned_after":8513.0,"shares_owned_after_display":"8,513","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-08-21","filed_date":"2019-08-23","scope":"insider","n_lines":2},{"id":7909621,"accession":"0000899243-19-022200","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-19-022200","line_url":"/filing/0000899243-19-022200#line-1","is_derivative":false,"issuer_cik":"0001427569","issuer_name":"Coherus BioSciences, Inc.","issuer_ticker":"CHRS","issuer_name_source":null,"issuer_url":"/issuer/0001427569","owner_cik":"0001427569","owner_name":"Viret Jean-Frederic","owner_display_name":"Viret Jean-Frederic","owner_url":"/insider/0001427569","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock, $0.0001 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3000.0,"shares_display":"3,000","price_per_share":19.04,"price_display":"19.04","price_state":"stated","total_value":57120.0,"total_display":"57,120.00","total_whole":"57,120","shares_owned_after":8513.0,"shares_owned_after_display":"8,513","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-08-19","filed_date":"2019-08-21","scope":"insider"},{"id":7879764,"accession":"0000899243-19-017621","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0000899243-19-017621","line_url":"/filing/0000899243-19-017621","is_derivative":false,"issuer_cik":"0001427569","issuer_name":"Coherus BioSciences, Inc.","issuer_ticker":"CHRS","issuer_name_source":null,"issuer_url":"/issuer/0001427569","owner_cik":"0001427569","owner_name":"Viret Jean-Frederic","owner_display_name":"Viret Jean-Frederic","owner_url":"/insider/0001427569","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock, $0.0001 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3826.0,"shares_display":"3,826","price_per_share":20.2789392577104,"price_display":"20.28","price_state":"stated","total_value":77587.2216,"total_display":"77,587.22","total_whole":"77,587","shares_owned_after":11613.0,"shares_owned_after_display":"11,613","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-06-19","filed_date":"2019-06-20","scope":"insider","n_lines":3},{"id":7879752,"accession":"0000899243-19-017621","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-19-017621","line_url":"/filing/0000899243-19-017621#line-1","is_derivative":false,"issuer_cik":"0001427569","issuer_name":"Coherus BioSciences, Inc.","issuer_ticker":"CHRS","issuer_name_source":null,"issuer_url":"/issuer/0001427569","owner_cik":"0001427569","owner_name":"Viret Jean-Frederic","owner_display_name":"Viret Jean-Frederic","owner_url":"/insider/0001427569","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock, $0.0001 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3000.0,"shares_display":"3,000","price_per_share":19.3088,"price_display":"19.31","price_state":"stated","total_value":57926.4,"total_display":"57,926.40","total_whole":"57,926","shares_owned_after":12180.0,"shares_owned_after_display":"12,180","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-06-18","filed_date":"2019-06-20","scope":"insider"},{"id":8114888,"accession":"0000899243-19-008784","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-19-008784","line_url":"/filing/0000899243-19-008784#line-1","is_derivative":false,"issuer_cik":"0001427569","issuer_name":"Coherus BioSciences, Inc.","issuer_ticker":"CHRS","issuer_name_source":null,"issuer_url":"/issuer/0001427569","owner_cik":"0001427569","owner_name":"Viret Jean-Frederic","owner_display_name":"Viret Jean-Frederic","owner_url":"/insider/0001427569","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock, $0.0001 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3000.0,"shares_display":"3,000","price_per_share":14.9207,"price_display":"14.92","price_state":"stated","total_value":44762.1,"total_display":"44,762.10","total_whole":"44,762","shares_owned_after":13185.0,"shares_owned_after_display":"13,185","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-03-20","filed_date":"2019-03-22","scope":"insider"},{"id":6316072,"accession":"0000899243-18-020572","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-18-020572","line_url":"/filing/0000899243-18-020572#line-1","is_derivative":false,"issuer_cik":"0001427569","issuer_name":"Coherus BioSciences, Inc.","issuer_ticker":"CHRS","issuer_name_source":null,"issuer_url":"/issuer/0001427569","owner_cik":"0001427569","owner_name":"Viret Jean-Frederic","owner_display_name":"Viret Jean-Frederic","owner_url":"/insider/0001427569","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock, $0.0001 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9291.0,"shares_display":"9,291","price_per_share":18.5633,"price_display":"18.56","price_state":"stated","total_value":172471.6203,"total_display":"172,471.62","total_whole":"172,472","shares_owned_after":3779.0,"shares_owned_after_display":"3,779","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-07-23","filed_date":"2018-07-25","scope":"insider"},{"id":5195841,"accession":"0000899243-17-002094","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-17-002094","line_url":"/filing/0000899243-17-002094#line-2","is_derivative":false,"issuer_cik":"0001427569","issuer_name":"Coherus BioSciences, Inc.","issuer_ticker":"CHRS","issuer_name_source":null,"issuer_url":"/issuer/0001427569","owner_cik":"0001427569","owner_name":"Viret Jean-Frederic","owner_display_name":"Viret Jean-Frederic","owner_url":"/insider/0001427569","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock, $0.0001 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3900.0,"shares_display":"3,900","price_per_share":27.0,"price_display":"27.00","price_state":"stated","total_value":105300.0,"total_display":"105,300.00","total_whole":"105,300","shares_owned_after":2992.0,"shares_owned_after_display":"2,992","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-01-25","filed_date":"2017-01-27","scope":"insider"},{"id":3108002,"accession":"0000899243-16-036028","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-16-036028","line_url":"/filing/0000899243-16-036028#line-2","is_derivative":false,"issuer_cik":"0001427569","issuer_name":"Coherus BioSciences, Inc.","issuer_ticker":"CHRS","issuer_name_source":null,"issuer_url":"/issuer/0001427569","owner_cik":"0001427569","owner_name":"Viret Jean-Frederic","owner_display_name":"Viret Jean-Frederic","owner_url":"/insider/0001427569","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock, $0.0001 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3900.0,"shares_display":"3,900","price_per_share":28.2987,"price_display":"28.30","price_state":"stated","total_value":110364.93,"total_display":"110,364.93","total_whole":"110,365","shares_owned_after":2325.0,"shares_owned_after_display":"2,325","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-12-16","filed_date":"2016-12-20","scope":"insider"},{"id":2942971,"accession":"0000899243-16-034104","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-16-034104","line_url":"/filing/0000899243-16-034104#line-2","is_derivative":false,"issuer_cik":"0001427569","issuer_name":"Coherus BioSciences, Inc.","issuer_ticker":"CHRS","issuer_name_source":null,"issuer_url":"/issuer/0001427569","owner_cik":"0001427569","owner_name":"Viret Jean-Frederic","owner_display_name":"Viret Jean-Frederic","owner_url":"/insider/0001427569","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock, $0.0001 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3900.0,"shares_display":"3,900","price_per_share":28.1936,"price_display":"28.19","price_state":"stated","total_value":109955.04,"total_display":"109,955.04","total_whole":"109,955","shares_owned_after":2325.0,"shares_owned_after_display":"2,325","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-11-18","filed_date":"2016-11-22","scope":"insider"},{"id":2641428,"accession":"0000899243-16-032269","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-16-032269","line_url":"/filing/0000899243-16-032269#line-2","is_derivative":false,"issuer_cik":"0001427569","issuer_name":"Coherus BioSciences, Inc.","issuer_ticker":"CHRS","issuer_name_source":null,"issuer_url":"/issuer/0001427569","owner_cik":"0001427569","owner_name":"Viret Jean-Frederic","owner_display_name":"Viret Jean-Frederic","owner_url":"/insider/0001427569","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock, $0.0001 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3900.0,"shares_display":"3,900","price_per_share":30.6161,"price_display":"30.62","price_state":"stated","total_value":119402.79,"total_display":"119,402.79","total_whole":"119,403","shares_owned_after":2325.0,"shares_owned_after_display":"2,325","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-10-21","filed_date":"2016-10-25","scope":"insider"},{"id":3032718,"accession":"0000899243-16-030224","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-16-030224","line_url":"/filing/0000899243-16-030224#line-2","is_derivative":false,"issuer_cik":"0001427569","issuer_name":"Coherus BioSciences, Inc.","issuer_ticker":"CHRS","issuer_name_source":null,"issuer_url":"/issuer/0001427569","owner_cik":"0001427569","owner_name":"Viret Jean-Frederic","owner_display_name":"Viret Jean-Frederic","owner_url":"/insider/0001427569","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock, $0.0001 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3900.0,"shares_display":"3,900","price_per_share":29.8846,"price_display":"29.88","price_state":"stated","total_value":116549.94,"total_display":"116,549.94","total_whole":"116,550","shares_owned_after":2325.0,"shares_owned_after_display":"2,325","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-09-26","filed_date":"2016-09-28","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":29,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":29,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":29},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001512762","name":"Coherus BioSciences, Inc.","url":"/issuer/0001512762","role":"Officer (Chief Financial Officer)","n_filings":23,"first_seen":"2016-09-28","last_seen":"2021-02-03"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001427569","retrieved_at":"2026-08-25T15:20:18+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-24","last_ingest":"2026-08-25T05:24:19.374141+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}